Objective. Epidural blood patch is the procedure of choice to relieve postdural puncture headache. Hydroxyethyl-starch (HES) has been proposed as a patch in some circumstances such as in the case of hematological disease due to the theoretical risk of neoplastic seeding to the central nervous system. Acute neurological HES toxicity has been excluded by a previous animal study, but the long-term neurological toxicity has not been evaluated.
Introduction
Postdural puncture headache (PDPH) due to intrathecal administration of chemotherapy agents, diagnostic lumbar puncture, and inadvertent dural puncture during epidural analgesia is well documented, and there are a rising number of requests for epidural patch [1] . Usually, epidural blood patch is the gold-standard treatment for postdural puncture headache when analgesics fail to relieve pain [2] [3] . However, the injection of autologous blood may be contraindicated in certain patients, particularly in the case of hematological disease due to the theoretical risk of neoplastic seeding to the central nervous system [4] [5] . Hydroxyethyl starch (HES) has been proposed as an alternative to blood in these specific circumstances [6] , and one ongoing study currently compares blood with HES in patients with PDPH [7] . This technique may a useful alternative to relieving PDPH symptoms by reducing the rate of cerebrospinal fluid (CSF) leak from the intrathecal space. Several clinical case reports of HES patch provide evidence that epidural HES is both beneficial and safe [8, 9] . A study involving 99 pregnant patients showed that HES can be used for epidural volume extension in a combined spinal-epidural anaesthesia technique for cesarean delivery without increasing the number of side effects compared with saline [9] . In a pig model, a single intrathecal HES injection did not induce any histopathological evidence of short-term neurotoxicity 10 hours after the injection of HES [10] . Moreover, a recent study in rats investigating the use of repeated colloids administered intrathecally did not find any potential neurotoxicity eight days later [11] .
Taken together, current evidence favors HES as a possible alternative to epidural blood patch. The aim of this experimental study was to assess possible long-term neurological complications associated with intrathecal HES administration in a rat model.
Methods
This experimental protocol was approved by the Animal Care Committee of Lyon (Rockefeller, Lyon, France, DR2014-58V2) and enacted according to the European guidelines (Directive EU 86/609) [12] .
The adult Sprague Dawley Oncins male rats used in this study were acquired from an experimental animal center and were kept in approved facilities (Envigo, Gannat, France). They were housed in individual acrylic cages, on a 12-hour light/dark cycle with free access to food and water (Teklad global diet 2018, Envigo, Gannat, France). Before experiments, the animals were allowed to acclimatize to housing facilities for seven days.
The cisternal intrathecal injection was performed using a modification of the protocol described by Nirogi et al. [13] (Figure 1 ). Each animal was placed in an induction chamber and anesthetized with 5% isoflurane in 50% oxygen. The fur on the neck region of the rat was removed using an Oster animal Clipper (Fisher Scientific, Pittsburgh, PA, USA). Anesthesia was maintained with isoflurane 1.5-2% given via a mask placed over the nose and mouth of the rat. Once anesthesia was induced, the animal's back was shaved and cleaned using an alcohol wipe in a sterile fashion. The animal was then placed in a prone position, and the head was flexed downward at approximately 45 so that a depressible surface with the appearance of a rhomboidal-shaped area between occipital protuberances and the spine of the atlas became visible. Percutaneous puncture of the cisternal subarachnoid space through the atlantooccipital membrane was performed using a 23-G needle by holding the rat securely by the pelvic girdle with one hand. This needle was connected to a Hamilton 50-lL syringe (Bonaduz, Switzerland), which was inserted horizontally and centrally into the cisterna magna for CSF collection without making any incision in this region. The syringe was removed, and the blunt end of the needle was then inserted into a 10-inch length of polypropylene PE-50 tubing (Smiths Medical International, St. Paul, MN, USA). The other end of the tubing was attached to the Hamilton syringe. The CSF could be observed to spontaneously flow into the PE-50 tubing. After collecting 20 lL, the equivalent of the dead space of the PE tubing, 40 lL of HES or normal saline was injected using the Hamilton syringe to prevent injection of air and so that the intrathecal injection was 20 lL.
The animals were randomized into three groups of 12 rats using a computer-generated table. According to the randomization group, rats received either 20 lL of normal saline 0.9% (saline group) or 20 lL of 6% hydroxyethyl starch 130/0.4 (HES group: Voluven; Fresenius Kabi, Sè vres, France), or the animal received no further intervention after dural puncture (puncture group). One subcutaneous injection of carprofen 5 mg kg À1 (Rimadyl; Pfizer Inc., New York, NY, USA) was provided to relieve postoperative pain.
Two veterinary assistants, blinded to the treatment, evaluated the rats three times per week for any signs indicating potential neurotoxicity including behavioral patterns, mobility and activity level, grooming and coat quality, tear secretion, absence of rearing up on the hind legs, abnormal movements, auditory reflex, palpebral reflex, startle reflex, and tail pinch. Abnormality in any of these areas was considered to be a sign of possible neurotoxicity. Activity was measured by actinometry (infrared activity meter; LE 8811, Infrared Actimeter; Bioseb, Vitrolles, France) over a 24-hour period. This was done seven days before and 28 days following dural puncture. The device used consists of a square frame supporting 16 infrared beams in each of two axes at right angles to one another. The device can record the total distance traveled, direction changes, and the number of rearings over a period of 24 hours.
Twenty-eight days after dural puncture, rats were killed by intravenous injection of pentobarbital. Brain, brainstem, and cervical spinal cord were extracted in one piece. The specimens were fixed in 10% buffered Long-term Neurotoxicity of Intrathecal HES in Rats formalin. Potential signs of neurotoxicity were investigated at injection site, and 0.5 cm and 1 cm from injection site. Tissue specimens were stained with hematoxylin-phloxine-saffron. The same neurological pathologist, blinded to group assignment, inspected the specimens using direct light microscopy for gross and microscopic alterations.
Statistical Analysis
Data were expressed as mean (SD). A KolmogorovSmirnov test was applied to verify the normality of the distribution. Within each study group, body weight and actimetry parameters were compared using a pairedsamples t test. At each study time point, the three experimental study groups were compared using a oneway analysis of variance (ANOVA). All analyses were performed using MedCalc software version 9.6.4.0 (MedCalc, Ostend, Belgium). A P value of <0.05 was considered statistically significant.
Results
Thirty-six rats were studied; 12 rats were randomly allocated to each group. One rat in the saline group and one rat in the puncture group did not complete the study because a neurologic deficit was apparent after surgical preparation and before injection.
For those rats that completed the study, there was no significant difference between groups in terms of activity (total distance traveled, number of direction changes, and number of rearings) or weight before intrathecal puncture. Although all animals gained weight over the course of the period of observation, there was no significant difference in the amount of weight gained between the study groups. Similarly, there was a significant decrease in the number of direction changes (P 0.02) and rearings (P 0.002) at final evaluation in all groups, but the distance traveled significantly decreased only in the saline group (P ¼ 0.01) over the course of the study. There was no significant difference between groups in terms of activity at final evaluation (Table 1) . No animal demonstrated change in behavior suggestive of neurotoxicity after puncture.
Histopathological investigation did not find any significant lesion; only artefacts were observed, such as dark neurons related to puncture, with no significant difference between the three groups.
Discussion
We found that single intrathecal administration of 20 mL of either HES or normal saline did not produce any histopathological or behavioral evidence of long-term neurotoxicity in rats.
Histological examination was performed 28 days after initiation of treatment. This time frame for the evaluation of long-term neurological toxicity has been validated in several published experimental dog or rat models [14] [15] [16] .
Our previous study that evaluated short-term neurotoxicity revealed no sign of inflammation in spinal cord specimens within eight days following intrathecal HES injection [9] . Inflammation is likely to be related to the chronic intrathecal catheterization used previously, whereas the current experimental model needed only a single spinal injection [13] .
Spinal toxicity of HES was studied using 20 mL of injectate administered into the CSF. Although there are no formal recommendations as to the volume to be used in adult rats, the volume used here is consistent with the volumes used to study pain and spinal toxicity in adult rat models [17] [18] [19] [20] . In neonatal rats, it has recently been recommended by Westin et al. [21] that 0.5-1-mL spinal volume injectate per gram bodyweight be used in spinal safety models. Application of this rule represents 150-300 mL in adults rats, an unrealistic intrathecal injectate volume. The 20-mL injection used in our rat model represented 8% of the total CSF volume of the rat (250 lL in the adult rat [22] ). This 20/250 mL ratio corresponds also approximately to the 12 mL given intraspinally in humans (CSF 150 mL in humans).
The 20-mL volume of HES is equivalent to a total dose of 1,200mg of hydroxyethyl starch, and the given concentration was 60 mg per mL of HES [23] . This concentration is anticipated to be large enough to detect neurotoxicity in rats because harmful threshold in cultured renal cells has been reported starting from 5-mg/mL HES and because HES was given intraspinally [23] . In humans, exposure would be less toxic because of the extradural injection site.
Yet none of the rats presented any behavior changes suggestive of neuronal toxicity. Moreover, there was no significant difference in terms of activity before and after the intrathecal puncture between the three studied groups. Rearing movements and direction changes significantly decreased 28 days after the intrathecal puncture in the three groups, and the distance traveled significantly decreased only in the saline group, which was accompanied by a significant increase in weight that is usual over this period of life.
The study has some limitations. First, the number of animals used in this study is smaller than desired, but it is consistent with the numbers used in other studies [14] . Second, repeated HES infusion was not investigated. A possibly more important point, but one that affects all animal pain studies, is the generalizability of the results to humans.
In conclusion, HES intrathecal injection did not induce any clinical or histopathological evidence of long-term neurotoxicity in our rat model. Further safety studies in animals are warranted before HES might be considered a safe alternative to the classic epidural blood patch.
Table 1
Objective assessment of daily activity before (day -7) and after (day 28) intrathecal puncture without any intracisternal injection (puncture group), intrathecal puncture with intrathecal injection of saline (saline group), and intrathecal puncture with intrathecal injection of 6% hydroxyethyl starch 130/0.4 (HES group) Data are expressed as mean (SD). Differences among groups at day -7 and day 28 were tested using one-way analysis of variance. Comparisons between day -7 and day 28 were performed using the paired-samples t test for each parameter. Statistically significant differences between day -7 and day 28 are reported. ANOVA ¼ analysis of variance; HES ¼ hydroxyethyl starch.
*P ¼ 0.01. **P ¼ 0.004. ***P < 0.001. ****P ¼ 0.02. *****P ¼ 0.002.
